Drug intelligence / Profile preview

xinxuening tablets

Development stage
Unknown
Lead developer
Shanxi Zhendong Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Xinxuening tablets are a Traditional Chinese Medicine (TCM) pharmaceutical product primarily composed of standardized extracts from *Pueraria lobata* (Kudzu root) and *Crataegus pinnatifida* (Hawthorn fruit). The formulation is rich in total flavonoids, including puerarin, which contribute to its therapeutic profile. Xinxuening is indicated for the treatment of cardiovascular and cerebrovascular conditions, including coronary heart disease, angina pectoris, and hyperlipidemia. Its mechanism of action involves promoting vasodilation, improving microcirculation, inhibiting platelet aggregation, and providing antioxidant protection against oxidative stress. In clinical practice, it is often used as an adjunctive treatment for acute ischemic stroke to support neurological recovery and improve clinical outcomes.

Brand names
Xinxuening
Other names
Xinxuening Pian心血宁片
02

Targets

ADRA1A (α1A)NO2- (Nitrite)

Beyond the preview

Go deeper on xinxuening tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xinxuening tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call